Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid

BACKGROUND: Bone represents one of the most common sites to which breast cancer cells metastasize. Patients experience skeletal related adverse events (pathological fractures, spinal cord compressions, and irradiation for deteriorated pain on bone) even during treatment with zoledronic acid (ZA). Th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Bone Oncol
Autori principali: Yanae, Masashi, Fujimoto, Shinichiro, Tane, Kaori, Tanioka, Maki, Fujiwara, Kimiko, Tsubaki, Masanobu, Yamazoe, Yuzuru, Morishima, Yoshiyuki, Chiba, Yasutaka, Takao, Shintaro, Komoike, Yoshifumi, Tsurutani, Junji, Nakagawa, Kazuhiko, Nishida, Shozo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581372/
https://ncbi.nlm.nih.gov/pubmed/28884071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2017.08.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi